Menu
Back to Journals » Drug Design, Development and Therapy » Volume 16
Retraction
Development of a Nanoliposomal Formulation of Erlotinib for Lung Cancer and in vitro/In vivo Antitumoral Evaluation [Retraction]
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 2,177 | Dovepress* | 2,093+ | 55 | 2,148 | |
| PubMed Central* | 84 | 48 | 132 | ||
| Totals | 2,177 | 103 | 2,280 | ||
| *Since 18 November 2022 | |||||
View citations on PubMed Central and Google Scholar